Diabetes device gets second chance for control group
NCT ID NCT07197788
Summary
This study offers a medical device treatment to people with type 2 diabetes who were in the placebo group of a previous trial. It aims to collect real-world safety and performance data on the Endogenex System, which is designed to help control blood sugar. The study will enroll about 50 eligible participants from the earlier trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.